Cristin-resultat-ID: 2095870
Sist endret: 16. februar 2023, 15:17
NVI-rapporteringsår: 2022
Resultat
Vitenskapelig oversiktsartikkel/review
2022

Use of Swedish smokeless tobacco during pregnancy: a systematic review of pregnancy and early life health risk

Bidragsytere:
  • Bendik Christian Brinchmann
  • Gunn Elisabeth Vist
  • Rune Becher
  • Tom Kristian Grimsrud
  • Ida-Kristin Ørjasæter Elvsaas
  • Vigdis Underland
  • mfl.

Tidsskrift

Addiction
ISSN 0965-2140
e-ISSN 1360-0443
NVI-nivå 2

Om resultatet

Vitenskapelig oversiktsartikkel/review
Publiseringsår: 2022
Publisert online: 2022
Open Access

Importkilder

Scopus-ID: 2-s2.0-85146346102

Beskrivelse Beskrivelse

Tittel

Use of Swedish smokeless tobacco during pregnancy: a systematic review of pregnancy and early life health risk

Sammendrag

Background and Aims: Smokeless tobacco is a heterogeneous product group with diverse composition and prevalence globally. Tobacco use during pregnancy is concerning due to the risk of adverse pregnancy outcomes and effects on child health. Nicotine may mediate several of these effects. This systematic review measured health outcomes from Swedish smokeless tobacco (snus) use during pregnancy. Method: Literature search was conducted by an information specialist in May 2022. We included human studies of snus use during pregnancy compared with no tobacco use, assessed risk of bias, conducted a meta-analysis and assessed confidence in effectestimates using Grading of Recommendations, Assessment, Development and Evaluations (GRADE). Results: We included 18 cohort studies (42 to 1 006 398 participants). Snus use during pregnancy probably (moderate confidence in risk estimates) increase the risk of neonatal apnea, adjusted odds ratio 95% confidence interval [aOR (95% CI)] 1.96 (1.30 to 2.96). Snus use during pregnancy possibly (low confidence in risk estimates) increase the risk of stillbirths aOR 1.43 (1.02 to 1.99), extremely premature births aOR 1.69 (1.17 to 2.45), moderately premature birth aOR 1.26 (1.15 to 1.38), SGA aOR 1.26 (1.09 to 1.46), reduced birth weight mean difference of 72.47 g (110.58 g to 34.35 g reduction) and oral cleft malformations aOR 1.48 (1.00 to 2.21). It is uncertain (low confidence in risk estimates, CI crossing 1) whether snus use during pregnancy affects risk of preeclampsia aOR 1.11 (0.97 to 1.28), antenatal bleeding aOR 1.15 (0.92 to 1.44) and very premature birth aOR 1.26 (0.95 to 1.66). Risk of early neonatal mortality and altered heart rate variability is uncertain, very low confidence. Snus using mothers had increased prevalence of caesarean sections, low confidence. Conclusions: This systematic review reveals that use of smokeless tobacco (snus) during pregnancy may adversely impact the developing child.

Bidragsytere

Bendik Christian Brinchmann

  • Tilknyttet:
    Forfatter
    ved Statens arbeidsmiljøinstitutt
  • Tilknyttet:
    Forfatter
    ved Klima og miljø ved Folkehelseinstituttet

Gunn Elisabeth Vist

  • Tilknyttet:
    Forfatter
    ved Avdeling for vurdering av tiltak ved Folkehelseinstituttet

Rune Becher

  • Tilknyttet:
    Forfatter
    ved Avdeling for luftkvalitet og støy ved Folkehelseinstituttet

Tom Kristian Grimsrud

  • Tilknyttet:
    Forfatter
    ved Kreftregisteret - Institutt for populasjonsbasert kreftforskning

Ida-Kristin Ørjasæter Elvsaas

  • Tilknyttet:
    Forfatter
    ved Avdeling for vurdering av tiltak ved Folkehelseinstituttet
1 - 5 av 14 | Neste | Siste »